The global anal cancer market is estimated to be valued at US$ 810.4 million in 2021 and is expected to exhibit a CAGR of 6.3% over the forecast period (2021-2028).
Global Anal Cancer Market: Drivers
High prevalence of anal cancer is expected to propel growth of the global anal cancer market over the forecast period. For example, the incidence rate of anal cancer increased by 41% in U.K with 15% increase in rate of anal cancer in males and 59% increase in females from 2015 to 2017, according to the Cancer Research U.K.
Moreover, funding for R&D is also expected to propel growth of the global anal cancer market over the forecast period. For example, the Icahn School of Medicine, New York, in August 2021, received a grant of around US$ 4 million from the National Cancer Institute for R&D in screening of anal cancer in women with HPV infection.
Market Trends
R&D in anal cancer is expected to propel growth of the global anal cancer market over the forecast period. For example, National Cancer Institute is conducting study to assess the effect of cetuximab used together with cisplatin, fluorouracil, and radiation therapy to treat immunocompromised patients suffering from stage I, II, or III anal cancer.
Covid-19 Impact Analysis
Globally, as of 5:50pm CET, 15 February 2022, there have been 412,351,279 confirmed cases of COVID-19, including 5,821,004 deaths, reported to WHO. As of 13 February 2022, a total of 10,227,670,521 vaccine doses have been administered.
Global Anal Cancer Market: Key Players
Major players operating in the global anal cancer market include, Amgen Inc., Atara Biotherapeutics Inc., Advaxis, Inc., Bristol-Myers Squibb Company, Bayer AG, BioMimetix JV, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Global BioPharma Inc., GlaxoSmithKline plc, ISA Pharmaceuticals, Johnson & Johnson Private Limited, Merck KGaA, Novartis AG, ORYX GmbH and Co. KG, Ono Pharmaceutical Co., Ltd., Onconova Therapeutics, LLC, Pfizer Inc., Spectrum Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Sanofi, and Takeda Pharmaceutical Company Limited.
Global Anal Cancer Market: Developments
Major players operating in the global anal cancer market are focused on adopting collaboration strategies to expand their product portfolio. For example, MacroGenics, Inc., in October 2017, collaborated with Incyte for MacroGenics, Inc.’s MGA012, an investigational monoclonal antibody, for the treatment of anal cancer, Merkel cell carcinoma, and others.
Major players operating in the global anal cancer market are also focused on R&D to expand their product portfolio. For instance, in December 2021, SQZ Biotechnologies Company reported that its investigational therapy induced radiographic, symptomatic and immune response as monotherapy in post-checkpoint HPV+ solid tumor patient.
Buy This Complete A Business Report
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Cancer Type
- Market Snippet, By Treatment Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Pipeline Analysis
- PEST Analysis
- Regulatory Scenario
- Market Trends
- Key Highlights
- Reimbursement Scenario
- Mergers & Acquisitions
- Market Dynamics
- Global Anal Cancer Market – Impact of Coronavirus (Covid-19) Pandemic
- Economic Impact
- Impact on Clinical Trials and Drug Development
- Government Initiatives
- Global Anal Cancer Market, By Drug Type, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Fluorouracil
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Cisplatin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Carboplatin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Others (Others include Mitomycin, Oxaliplatin, Docetaxel, Leucovorin, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Global Anal Cancer Market, By Cancer Type, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Carcinoma In-situ
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Squamous Cell Carcinoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Melanoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Adenocarcinoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Basal Cell Carcinoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Global Anal Cancer Market, By Treatment Type, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Chemotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Radiation Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Global Anal Cancer Market, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Research & Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Long-term Care Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
About US:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837